Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drugHao Wu, Fredrik Bäckhed, Eduardo Esteve et al.|Nature Medicine|2017Cited by 1.6k
Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide SynthaseHervé Duplain, Urs Scherrer, Rémy Burcelin et al.|Circulation|2001Cited by 535
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivityBenoı̂t Viollet, Sophie Vaulont, Fabrizio Andréelli et al.|Journal of Clinical Investigation|2003Cited by 488
Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient miceMario Pende, George Thomas, Sara C. Kozma et al.|Nature|2000Cited by 454
Liver Adenosine Monophosphate-Activated Kinase-α2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not InsulinFabrizio Andréelli, Benoı̂t Viollet, Marc Foretz et al.|Endocrinology|2006Cited by 229